Argonautica Private Wealth Management’s AstraZeneca AZN Stock Holding History

Argonautica Private Wealth Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$806K	Buy	4,087 +406	+11%	+$78.3K	0.24%	83
2025 Q4	$677K	Buy	3,681 +1,201	+48%	+$211K	0.2%	97
2025 Q3	$380K	Buy	2,480 +205	+9%	+$31K	0.11%	145
2025 Q2	$318K	Sell	2,275 -7	-0.3%	-$981	0.1%	158
2025 Q1	$335K	Buy	2,282 +317	+16%	+$45.9K	0.12%	152
2024 Q4	$257K	Buy	1,965 +18	+0.9%	+$2.52K	0.08%	182
2024 Q3	$303K	Buy	1,947 +10	+0.5%	+$1.61K	0.1%	167
2024 Q2	$302K	Buy	1,937 +74	+4%	+$11.1K	0.1%	158
2024 Q1	$252K	Sell	1,863 -116	-6%	-$15.4K	0.09%	179
2023 Q4	$266K	Buy	1,979 +28	+1%	+$3.64K	0.11%	166
2023 Q3	$264K	Buy	1,951 +20	+1%	+$2.73K	0.12%	162
2023 Q2	$276K	Buy	+1,931	New	+$284K	0.12%	158

Other funds holding AZN

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VAM

Vanguard Asset Management London, Ec4n 8af $117B AUM

Argonautica Private Wealth Management's AZN Position: Q1 2026 in Review

Argonautica Private Wealth Management increased its AstraZeneca (AZN) stake by 11% in Q1 2026, buying an estimated $78.3K and bringing the position to 4,087 shares worth $806K. The position accounts for 0.24% of the portfolio, ranked #83.

Argonautica Private Wealth Management first reported a position in AZN in Q2 2023 and has held it in 12 quarters since. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

Argonautica Private Wealth Management held 4,087 shares of AstraZeneca worth $806K as of Q1 2026.
Argonautica Private Wealth Management bought 406 AstraZeneca shares in Q1 2026, an estimated $78.3K.
AstraZeneca made up 0.24% of Argonautica Private Wealth Management's portfolio in Q1 2026, its #83 holding.
Argonautica Private Wealth Management first reported a position in AstraZeneca in Q2 2023 and has held it in 12 quarters since.
1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Argonautica Private Wealth Management's 13F filing for Q1 2026, filed 28 Apr 2026.